Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Files Infringement Suit Against Ibis

NEW YORK (GenomeWeb News) – Sequenom President and CEO Harry Stylli said during the firm’s third-quarter conference call last night that the firm had filed a patent infringement suit against Ibis Biosciences for allegedly infringing three Sequenom patents related to nucleic acid analysis by mass spectrometry.
He offered few details about the suit, which was filed against the subsidiary of Carlsbad, Calif.-based Isis Pharmaceuticals yesterday in the US District Court in the District of Delaware. The filing does not yet appear on the court’s website.
Stylli alleged that Ibis’ T5000 Biosensor System and related technology infringes the Sequenom patents. He said the firm is seeking a permanent injunction that would bar the sale of the biosensor and related technologies as well as monetary damages.
Responding to a question during the call regarding legal expenses associated with the action against Ibis, Stylli said that those expected costs have already been built into the firm’s expectations for SG&A expenses. He declined to comment further on the cost, other than saying, “it’s not expected to be that much in the next 12 months. Frankly, we’re hoping that we’ll work out some kind of business solution.”
While Ibis is currently owned by Isis Pharmaceuticals, Abbott holds a nearly 20 percent stake in the subsidiary with an option to buy the remainder of Ibis through June 2009.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.